Anxiety and Related Sleep Disorders - Serbia

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$9.91m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.52%, resulting in a market volume of US$10.69m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$30.42 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Serbia is experiencing significant growth and development due to several key factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the current state of the market.Customer preferences play a crucial role in the development of the Anxiety and Related Sleep Disorders market in Serbia. As awareness about mental health and the importance of quality sleep increases, more individuals are seeking treatment for anxiety and related sleep disorders. Customers are looking for effective and accessible solutions to manage their symptoms, which has led to a growing demand for pharmaceutical products and therapeutic interventions.In line with global trends, the market in Serbia is witnessing a shift towards more personalized and holistic approaches to anxiety and sleep disorders. Customers are increasingly interested in natural remedies, such as herbal supplements and aromatherapy, as well as non-pharmaceutical interventions, including cognitive-behavioral therapy and mindfulness practices. This trend reflects a growing awareness of the potential side effects and long-term consequences of traditional pharmaceutical treatments.Additionally, the market is seeing an increase in the availability and accessibility of telemedicine services. This allows individuals to consult with healthcare professionals remotely, making it easier for those in remote areas or with limited mobility to access the necessary care. The convenience and flexibility of telemedicine have contributed to the overall growth of the market in Serbia.Local special circumstances also influence the development of the Anxiety and Related Sleep Disorders market in Serbia. The country has a high prevalence of mental health issues, including anxiety disorders and insomnia. This has created a significant demand for effective treatments and interventions. The healthcare system in Serbia is working to address these needs by expanding mental health services and increasing the availability of specialized healthcare professionals.Furthermore, Serbia is experiencing economic growth and development, which has led to an increase in disposable income and healthcare spending. As individuals have more financial resources, they are more likely to seek treatment for anxiety and sleep disorders. This has contributed to the overall growth of the market in Serbia.In conclusion, the Anxiety and Related Sleep Disorders market in Serbia is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Increased awareness of mental health, a shift towards personalized and holistic approaches, the availability of telemedicine services, high prevalence of mental health issues, and economic growth all contribute to the growth and development of the market in Serbia.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.